By Adam Levine:
Overview and Peer Group
Lululemon (NASDAQ:LULU) is a technical apparel designer and retailer that offers a wide and deep range of products for athletic pursuits such as yoga, running, general fitness and other athletic...
Why degrowth a sustainable alternative to traditional growth-based business is gaining traction across the globe
In mainstream economics and politics, growth is a largely unquestioned good, generally associated with positive attributes like...
iRobot Corporation (NASDAQ:IRBT)
Q2 2014 Results Earnings Conference Call
July 23, 2014, 08:30 AM ET
Elise Caffrey - Investor Relations
Colin Angle - Chairman and CEO
Alison Dean - CFO
Jim Ricchiuti -...
InterMune secured the FDA's breakthrough therapy designation for an in-development treatment for a rare lung disease, evening the regulatory score with rival Boehringer Ingelheim as the two angle for position on the U.S. market.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.